CCL2 and colorectal carcinoma: To further confirm that FOXQ1 promotes tumor angiogenesis and modifies the TME in CRC, tumor tissues from 83 patients diagnosed with CRC were used to evaluate the expression of FOXQ1, Twist1, CCL2, CD68, and CD31.